EAM
KRTX
Eventide Asset Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-190,000
| Closed | -$60.1M | – | 174 |
|
|
2023
Q4 | $60.1M | Sell |
190,000
-149,840
| -44% | -$47.4M | 0.98% | 39 |
|
|
2023
Q3 | $57.5M | Sell |
339,840
-128
| -0% | -$21.6K | 1.03% | 32 |
|
|
2023
Q2 | $73.7M | Buy |
339,968
+70
| +0% | +$15.2K | 1.25% | 27 |
|
|
2023
Q1 | $61.7M | Sell |
339,898
-179,802
| -35% | -$32.7M | 1.13% | 28 |
|
|
2022
Q4 | $102M | Hold |
519,700
| – | – | 2.01% | 12 |
|
|
2022
Q3 | $117M | Sell |
519,700
-99,700
| -16% | -$22.4M | 2.3% | 4 |
|
|
2022
Q2 | $78.4M | Sell |
619,400
-128,600
| -17% | -$16.3M | 1.68% | 19 |
|
|
2022
Q1 | $94.8M | Hold |
748,000
| – | – | 1.49% | 27 |
|
|
2021
Q4 | $98M | Hold |
748,000
| – | – | 1.25% | 30 |
|
|
2021
Q3 | $91.5M | Hold |
748,000
| – | – | 1.21% | 29 |
|
|
2021
Q2 | $85.3M | Sell |
748,000
-223,077
| -23% | -$25.4M | 1.15% | 34 |
|
|
2021
Q1 | $117M | Buy |
971,077
+70,000
| +8% | +$8.42M | 1.73% | 13 |
|
|
2020
Q4 | $91.5M | Hold |
901,077
| – | – | 1.4% | 19 |
|
|
2020
Q3 | $69.7M | Hold |
901,077
| – | – | 1.36% | 21 |
|
|
2020
Q2 | $100M | Hold |
901,077
| – | – | 2.18% | 8 |
|
|
2020
Q1 | $64.9M | Buy |
901,077
+686,234
| +319% | +$49.4M | 2.1% | 7 |
|
|
2019
Q4 | $16.2M | Sell |
214,843
-81,157
| -27% | -$6.11M | 0.46% | 67 |
|
|
2019
Q3 | $4.83M | Sell |
296,000
-840,234
| -74% | -$13.7M | 0.16% | 84 |
|
|
2019
Q2 | $22.1M | Buy |
+1,136,234
| New | +$22.1M | 0.67% | 56 |
|